GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 1.98% to Rs 257.49 crore in the quarter ended September 2025 as against Rs 252.50 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 979.94 crore in the quarter ended September 2025 as against Rs 1010.77 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales979.941010.77 -3 OPM %34.2631.83 - PBDT368.79355.98 4 PBT351.36339.12 4 NP257.49252.50 2 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 12.44% to Rs 205.01 crore in the quarter ended June 2025 as against Rs 182.33 crore during the previous quarter ended June 2024. Sales declined 1.16% to Rs 805.17 crore in the quarter ended June 2025 as against Rs 814.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales805.17814.65 -1 OPM %31.2028.30 - PBDT294.50265.81 11 PBT278.98249.40 12 NP205.01182.33 12 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live News